Alerts in the last 24 hours

No Personalised Alerts!

To see personalised alerts you need to be logged in.

Log In

Spire Healthcare Group PLC Add to portfolio

LON250:SPI, Sep 22, 11:31 UTC

Latest LON250:SPI News

Filter your feed

Apply Filter

Wednesday, September 18


News

Spire Healthcare Group (LON:SPI) Stock Rating Reaffirmed by Peel Hunt – Slater Sentinel

SPI

Peel Hunt’s target price indicates a potential upside of 34.55% from the stock’s current price. Royal Bank of Canada reissued an “outperform” rating and set a GBX 149 ($1.95) price objective on shares of Spire Healthcare Group in a research note on Monday, September 9th. Two investment analysts have rated the stock with a sell rating, six have given a hold rating and two have issued a buy rating to the company. Spire Healthcare Group has a 1-year low of GBX 95.25 ($1.24) and a 1-year high of GBX 176 ($2.30).

Read Full Details

Topics:
  • Business
  • Financial
  • Health

Tuesday, September 17


News

Spire Healthcare Group (LON:SPI) Rating Reiterated by Royal Bank of Canada – Mayfield Recorder

SPI

A number of other research analysts also recently commented on the stock. Numis Securities reissued a “buy” rating and issued a GBX 163 ($2.13) target price (down from GBX 280 ($3.66)) on shares of Spire Healthcare Group in a research report on Thursday, May 16th. Spire Healthcare Group presently has a consensus rating of “Hold” and a consensus price target of GBX 129.40 ($1.69). Spire Healthcare Group has a 52-week low of GBX 95.25 ($1.24) and a 52-week high of GBX 176 ($2.30).

Read Full Details

Topics:
  • Business
  • Health
  • Financial

Tuesday, September 10


News

Spire Healthcare Group (LON:SPI) Given “Outperform” Rating at Royal Bank of Canada – Slater Sentinel

SPI

Numis Securities reiterated a buy rating and set a GBX 163 ($2.13) price target (down previously from GBX 280 ($3.66)) on shares of Spire Healthcare Group in a research note on Thursday, May 16th. Two equities research analysts have rated the stock with a sell rating, five have given a hold rating and two have given a buy rating to the company. Spire Healthcare Group presently has a consensus rating of Hold and an average target price of GBX 126.56 ($1.65). Spire Healthcare Group has a 12-month low of GBX 95.25 ($1.24) and a 12-month high of GBX 176 ($2.30).

Read Full Details

Topics:
  • Business
  • Health
  • Financial
News

Spire Healthcare Group (LON:SPI) Given “Outperform” Rating at Royal Bank of Canada – Mayfield Recorder

SPI

Numis Securities reiterated a buy rating and set a GBX 163 ($2.13) price target (down previously from GBX 280 ($3.66)) on shares of Spire Healthcare Group in a research note on Thursday, May 16th. Two equities research analysts have rated the stock with a sell rating, five have given a hold rating and two have given a buy rating to the company. Spire Healthcare Group presently has a consensus rating of Hold and an average target price of GBX 126.56 ($1.65). Spire Healthcare Group has a 12-month low of GBX 95.25 ($1.24) and a 12-month high of GBX 176 ($2.30).

Read Full Details

Topics:
  • Business
  • Health
  • Financial

Monday, September 02


News

Spire Healthcare Group (LON:SPI) Stock Rating Reaffirmed by Barclays – Riverton Roll

SPI

Numis Securities reaffirmed a buy rating and set a GBX 163 ($2.13) price target (down previously from GBX 280 ($3.66)) on shares of Spire Healthcare Group in a report on Thursday, May 16th. Two equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and one has given a buy rating to the company’s stock. Spire Healthcare Group presently has a consensus rating of Hold and a consensus price target of GBX 123.75 ($1.62). Spire Healthcare Group has a 1-year low of GBX 95.25 ($1.24) and a 1-year high of GBX 178.90 ($2.34).

Read Full Details

Topics:
  • Business
  • Health
  • Financial

Wednesday, August 21


News

Spire Healthcare Group’s (SPI) Hold Rating Reaffirmed at Liberum Capital – Mayfield Recorder

SPI

Numis Securities reaffirmed a buy rating and set a GBX 163 ($2.13) price target (down previously from GBX 280 ($3.66)) on shares of Spire Healthcare Group in a report on Thursday, May 16th. Two research analysts have rated the stock with a sell rating, five have issued a hold rating and one has issued a buy rating to the stock. Shares of Spire Healthcare Group stock opened at GBX 98.90 ($1.29) on Monday. Spire Healthcare Group has a 1 year low of GBX 95.25 ($1.24) and a 1 year high of GBX 178.90 ($2.34).

Read Full Details

Topics:
  • Business
  • Health
  • Financial

Sunday, August 11


News

Spire Healthcare Group (LON:SPI) Stock Rating Reaffirmed by Barclays – Riverton Roll

SPI

Numis Securities restated a “buy” rating and set a GBX 163 ($2.13) target price (down previously from GBX 280 ($3.66)) on shares of Spire Healthcare Group in a report on Thursday, May 16th. Two analysts have rated the stock with a sell rating, five have issued a hold rating and one has issued a buy rating to the company. The company currently has an average rating of “Hold” and an average price target of GBX 123.75 ($1.62). Spire Healthcare Group has a 52 week low of GBX 95.25 ($1.24) and a 52 week high of GBX 178.90 ($2.34).

Read Full Details

Topics:
  • Business
  • Health
  • Financial

Friday, August 09


News

Barclays Capital Keeps Its "Underweight" Rating on Spire Healthcare Group (LON:SPI) Shares Today

SPI

Among 4 analysts covering Spire Healthcare Group (LON:SPI), 1 have Buy rating, 1 Sell and 2 Hold. Therefore 25% are positive. Spire Healthcare Group had 19 analyst reports since February 12, 2019 according to SRatingsIntel. The stock of Spire Healthcare Group plc (LON:SPI) earned “Underperform” rating by Credit Suisse on Wednesday, March 13. As per Friday, April 12, the company rating was maintained by Barclays Capital. The stock decreased 1.31% or GBX 1.32 during the last trading session, reaching GBX 99.38.

Read Full Details

Topics:
  • Business
  • Health
  • Financial

Monday, August 05


News

Spire Healthcare extends agreement with Bupa to 2022

SPI

Spire Healthcare extends agreement with Bupa to 2022. 5 August 2019 | 07:52am. StockMarketWire.com - Hospital owner Spire Healthcare said it had agreed to extend an existing collaboration agreement with health insurer Bupa. The contract's minimum term had been extended to March 2022, with agreed pricing during the period. 'The agreement reflects the strong working relationship between Spire and Bupa,' Spire said in a short statement. Story provided by StockMarketWire.com. LATEST STOCK MARKET NEWS AND OFFERS. Get the latest stock market and investment news, market wraps, promotions and more!

Read Full Details

Topics:
  • Business
  • Health
  • Financial

Sunday, July 28


News

Spire Healthcare Group (LON:SPI) Stock Rating Reaffirmed by Liberum Capital – Riverton Roll

SPI

Spire Healthcare Group (LON:SPI)‘s stock had its “hold” rating reaffirmed by research analysts at Liberum Capital in a research note issued on Thursday, July 11th, ThisIsMoney.Co.Uk reports. Finally, Barclays lowered their target price on BT Group from GBX 250 ($3.27) to GBX 240 ($3.14) and set an “equal weight” rating for the company in a research note on Friday, May 10th. Two equities research analysts have rated the stock with a sell rating, six have given a hold rating and one has issued a buy rating to the stock. Spire Healthcare Group has a 1-year low of GBX 96.15 ($1.26) and a 1-year high of GBX 253.60 ($3.31).

Read Full Details

Topics:
  • Business
  • Health
  • Financial